{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:00:22Z","timestamp":1792425622438,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009096","name":"Firat \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jpurol.2019.03.021","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T03:05:44Z","timestamp":1553915144000},"page":"378.e1-378.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The use of nitrofurantoin for children with acute cystitis caused by extended-spectrum \u0392-lactamase\u2013producing Escherichia coli"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4410-0444","authenticated-orcid":false,"given":"A.","family":"Kara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0645-8170","authenticated-orcid":false,"given":"M.K.","family":"Gurgoze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2019.03.021_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10156-013-0606-9","article-title":"Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus","volume":"19","author":"Hayami","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jpurol.2019.03.021_bib2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijantimicag.2010.10.032","article-title":"Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008)","volume":"37","author":"Matsumoto","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jpurol.2019.03.021_bib3","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00467-009-1431-3","article-title":"Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children","volume":"25","author":"Topaloglu","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpurol.2019.03.021_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-018-1148-y","article-title":"Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study","author":"Almomani","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.jpurol.2019.03.021_bib5","first-page":"21","article-title":"Urinary tract infection: one lingering effect of childhood kidney diseases--review of the literature","volume":"20","author":"Vachvanichsanong","year":"2007","journal-title":"J Nephrol"},{"key":"10.1016\/j.jpurol.2019.03.021_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMra1007755","article-title":"Febrile urinary tract infections in children","volume":"365","author":"Montini","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpurol.2019.03.021_bib7","series-title":"Pediatric nephrology","first-page":"1299","article-title":"Pediatric nephrology","author":"Avner","year":"2009"},{"key":"10.1016\/j.jpurol.2019.03.021_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jiac.2017.04.006","article-title":"Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli","volume":"23","author":"Abe","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jpurol.2019.03.021_bib9","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2017"},{"key":"10.1016\/j.jpurol.2019.03.021_bib10","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/CCM.0b013e318169eda9","article-title":"Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America","volume":"36","author":"O'Grady","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jpurol.2019.03.021_bib11","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jiac.2014.08.007","article-title":"Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae","volume":"20","author":"Ipekci","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jpurol.2019.03.021_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s15010-011-0132-6","article-title":"Extended-spectrum \u03b2-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy","volume":"39","author":"Meier","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.jpurol.2019.03.021_bib13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1442-200X.2012.03709.x","article-title":"Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children","volume":"54","author":"Kizilca","year":"2012","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jpurol.2019.03.021_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jmii.2013.05.006","article-title":"Rise of community-onset urinary tract infection caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli in children","volume":"47","author":"Fan","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jpurol.2019.03.021_bib15","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00467-014-2810-y","article-title":"Extended-spectrum \u03b2-lactamase-producing bacteria causing community-acquired urinary tract infections in children","volume":"29","author":"Megged","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpurol.2019.03.021_bib16","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jac\/dkl035","article-title":"Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases","volume":"57","author":"Calbo","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jpurol.2019.03.021_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/ped.13112","article-title":"Childhood urinary tract infection caused by extended-spectrum \u03b2-lactamase-producing bacteria: risk factors and empiric therapy","volume":"59","author":"Uyar Aksu","year":"2017","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jpurol.2019.03.021_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijantimicag.2012.08.003","article-title":"Nitrofurantoin in the treatment of extended-spectrum \u03b2-lactamase-producing Escherichia\u00a0coli-related lower urinary tract infection","volume":"40","author":"Tasbakan","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jpurol.2019.03.021_bib19","series-title":"Principles and practice of infectious diseases","first-page":"515","article-title":"Urinary tract agents: nitrofurantoin and methenamine","author":"Hooper","year":"2010"},{"key":"10.1016\/j.jpurol.2019.03.021_bib20","series-title":"[2012-2016 y\u0131llar\u0131 aras\u0131nda \u00fcriner sistem enfeksiyonu saptanan \u00e7ocuk hastalarda izole edilen bakterilerin antibiyotik duyarl\u0131l\u0131klar\u0131]. 53. T\u00fcrk Pediatri Kongresi. 14-18","author":"Kara","year":"2017"},{"key":"10.1016\/j.jpurol.2019.03.021_bib21","first-page":"68","article-title":"Spanish Surveillance Group for Urinary Pathogens. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain","volume":"20","author":"Gobernado","year":"2007","journal-title":"Rev Espa\u00f1ola Quimioter"},{"key":"10.1016\/j.jpurol.2019.03.021_bib22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/jinf.2002.1091","article-title":"A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection","volume":"46","author":"Farrell","year":"2003","journal-title":"J Infect"},{"key":"10.1016\/j.jpurol.2019.03.021_bib23","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/jac\/dkv147","article-title":"Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials","volume":"70","author":"Huttner","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jpurol.2019.03.021_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.medmal.2013.01.006","article-title":"Alternatives to carbapenems in ESBL-producing Escherichia coli infections","volume":"43","author":"Fournier","year":"2013","journal-title":"Med Maladies Infect"},{"key":"10.1016\/j.jpurol.2019.03.021_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/jgid.jgid_72_17","article-title":"Nitrofurantoin and fosfomycin for extended spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniae","volume":"10","author":"Tulara","year":"2018","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.jpurol.2019.03.021_bib26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11255-015-1018-9","article-title":"Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin","volume":"47","author":"Cho","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jpurol.2019.03.021_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/23744235.2015.1087648","article-title":"The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011","volume":"48","author":"Zykov","year":"2016","journal-title":"Inf Disp"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513118304236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513118304236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:45:38Z","timestamp":1761486338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513118304236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1477513118304236"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2019.03.021","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of nitrofurantoin for children with acute cystitis caused by extended-spectrum \u0392-lactamase\u2013producing Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2019.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}